Value of Magnetic Resonance Imaging for Nodal Staging in Patients with Head and Neck Squamous Cell Carcinoma: A Meta-analysis

Academic Radiology

Volumn 19, Issue 3, 2012, Pages 331-340

  Wu, Lian Ming ^a   Xu, Jian Rong ^a   Liu, Man Ju ^b   Zhang, Xiao Fei ^a   Hua, Jia ^a   Zheng, Jasmine ^c   Hu, Jia Ni ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WAYNE STATE UNIVERSITY   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

HNSCC; Meta analysis; MRI; Nodal staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84856622591     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.10.027     Document Type: Article

References (45)

1. Johnson J.T. A surgeon looks at cervical lymph nodes. Radiology 1990, 175:607-610.
2. Singh K., Orakwue C.O., Honest H., et al. Accuracy of magnetic resonance imaging of inguinofemoral lymph nodes in vulval cancer. Int J Gynecol Cancer 2006, 16:1179-1183.
3. Kvistad K.A., Rydland J., Smethurst H.B., et al. Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI. Eur Radiol 2000, 10:1464-1471.
4. Castelijns J.A., van den Brekel M.W. Imaging of lymphadenopathy in the neck. Eur Radiol 2002, 12:727-738.
5. Castelijns J.A., van den Brekel M.W. Detection of lymph node metastases in the neck: radiologic criteria. AJNR Am J Neuroradiol 2001, 22:3-4.
6. Feinmesser R., Freeman J.L., Feinmesser M., et al. Role of modern imaging in decision-making for elective neck dissection. Head Neck 1992, 14:173-176.
7. Som P.M. Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR Am J Roentgenol 1992, 158:961-969.
8. Ashraf M., Biswas J., Jha J., et al. Clinical utility and prospective comparison of ultrasonography and computed tomography imaging in staging of neck metastases in head and neck squamous cell cancer in an Indian setup. Int J Clin Oncol 2011 Jun 16, [Epub ahead of print].
9. Whiting P., Rutjes A.W., Reitsma J.B., et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25.
10. Rutter C.M., Gatsonis C.A. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med 2001, 20. 2865-284.
11. Harbord R.M., Deeks J.J., Egger M., et al. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007, 8:239-251.
12. Swets J.A. Measuring the accuracy of diagnostic systems. Science 1988, 240:1285-1293.
13. Vandecaveye V., De Keyzer F., Dirix P., et al. Applications of diffusion-weighted magnetic resonance imaging in head and neck squamous cell carcinoma. Neuroradiology 2010, 52:773-784.
14. Pons Y., Ukkola-Pons E., Clément P., et al. Relevance of 5 different imaging signs in the evaluation of carotid artery invasion by cervical lymphadenopathy in head and neck squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109:775-778.
15. Cianchetti M., Mancuso A.A., Amdur R.J., et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 2009, 119:2348-2354.
16. Jansen J.F., Schöder H., Lee N.Y., et al. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys 2010, 77:1403-1410.
17. Mendenhall W.M., Mancuso A.A., Parsons J.T., et al. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Head Neck 1998, 20:739-744.
18. Di Martino E., Nowak B., Krombach G.A., et al. Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET). Laryngorhinootologie 2000, 79:201-206.
19. Okita W., Sasaki T., Takamatsu S., et al. Object analysis of cervical lymph nodes using MRI turbo-STIR sequence in cases of head and neck tumors. Nippon Jibiinkoka Gakkai Kaiho 1999, 102:1-7.
20. Tuli H.S., Singh B., Prasad V., et al. Diagnostic accuracy of 99mTc-MIBI-SPECT in the detection of lymph node metastases in patients with carcinoma of the tongue: comparison with computed tomography and MRI. Nucl Med Commun 2008, 29:803-808.
21. Wilson G.R., McLean N.R., Chippindale A., et al. The role of MRI scanning in the diagnosis of cervical lymphadenopathy. Br J Plast Surg 1994, 47:175-179.
22. van den Brekel M.W., Castelijns J.A., et al. Magnetic resonance imaging vs palpation of cervical lymph node metastasis. Arch Otolaryngol Head Neck Surg 1991, 117:663-673.
23. Dirix P., Vandecaveye V., De Keyzer F., et al. Diffusion-weighted MRI for nodal staging of head and neck squamous cell carcinoma: impact on radiotherapy planning. Int J Radiat Oncol Biol Phys 2010, 76:761-766.
24. Vandecaveye V., De Keyzer F., Vander Poorten V., et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009, 251:134-146.
25. Yoon D.Y., Hwang H.S., Chang S.K., et al. CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 2009, 19:634-642.
26. Krabbe C.A., Dijkstra P.U., Pruim J., et al. FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases. Oral Oncol 2008, 44:31-36.
27. Hafidh M.A., Lacy P.D., Hughes J.P., et al. Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas. Eur Arch Otorhinolaryngol 2006, 263:853-859.
28. Akoĝlu E., Dutipek M., Bekiş R., et al. Assessment of cervical lymph node metastasis with different imaging methods in patients with head and neck squamous cell carcinoma. J Otolaryngol 2005, 34:384-394.
29. Brouwer J., de Bree R., Comans E.F., et al. Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck:is it likely to be superior?. Eur Arch Otorhinolaryngol 2004, 261:479-483.
30. Sigal R., Vogl T., Casselman J., et al. Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR)-results of a phase-III multicenter clinical trial. Eur Radiol 2002, 12:1104-1113.
31. Stuckensen T., Kovács A.F., Adams S., et al. Staging of the neck in patientswith oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 2000, 28:319-324.
32. Curtin H.D., Ishwaran H., Mancuso A.A., et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998, 207:123-130.
33. Adams S., Baum R.P., Stuckensen T., et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998, 25:1255-1260.
34. Laubenbacher C., Saumweber D., Wagner-Manslau C., et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995, 36:1747-1757.
35. Braams J.W., Pruim J., Freling N.J., et al. Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI. JNucl Med 1995, 36:211-216.
36. Anzai Y., Blackwell K.E., Hirschowitz S.L., et al. Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer. Radiology 1994, 192:709-715.
37. van den Brekel M.W., Castelijns J.A., Stel H.V., et al. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993, 250:11-17.
38. Feinmesser R., Freeman J.L., Noyek A.M., et al. MRI and neck metastases: a clinical, radiological, pathological correlative study. J Otolaryngol 1990, 19:136-140.
39. Jones C.M., Athanasiou T. Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 2005, 79:16-20.
40. Zamora J., Abraira V., Muriel A., et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31.
41. Kim J.K., Kim K.A., Park B.W., et al. Feasibility of diffusion-weighted imaging in the differentiation of metastatic from nonmetastatic lymph nodes: early experience. J Magn Reson Imaging 2008, 28:714-719.
42. Holzapfel K., Duetsch S., Fauser C., et al. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009, 72:381-387.
43. Ono K., Ochiai R., Yoshida T., et al. Comparison of diffusion-weighted MRIand 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography (FDGPET) for detecting primary colorectal cancer and regional lymph node metastases. J Magn Reson Imaging 2009, 29:336-340.
44. Nomori H., Mori T., Ikeda K., et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for Nstaging of non-small cell lung cancer with fewer false-positive results. JThorac Cardiovasc Surg 2008, 135:816-822.
45. Pauls S., Schmidt S.A., Juchems M.S., et al. Diffusion-weighted MR imagingin comparison to integrated [(18)F]-FDG PET/CT for N-staging inpatients with lung cancer. Eur J Radiol 2010 Oct 5, [Epub ahead ofprint].